Trileptal and Bronchospasm - a phase IV clinical study of FDA data

Summary:

Bronchospasm is reported as a side effect among people who take Trileptal (oxcarbazepine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Azopt, and have Seizures.

The phase IV clinical study analyzes which people have Bronchospasm when taking Trileptal. It is created by eHealthMe based on reports of 22,012 people who have side effects when taking Trileptal from the FDA, and is updated regularly.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.

What is Bronchospasm?

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi) is found to be associated with 1,121 drugs and 1,099 conditions by eHealthMe. Check the latest studies of Bronchospasm.

On Jul, 28, 2026

22,012 people reported to have side effects when taking Trileptal.
Among them, 24 people (0.11%) have Bronchospasm.

Among these 24 people:

How long have people been on Trileptal when they have Bronchospasm? *

What is the gender of people who have Bronchospasm when taking Trileptal? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Bronchospasm when taking Trileptal? *

What are other drugs people take besides Trileptal? *

What are other side effects people have besides Bronchospasm? *

Dyspnea (difficult or laboured breathing): 10 people, 41.67%
Chest Pain: 5 people, 20.83%
Pneumonia: 4 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 16.67%
Cough: 4 people, 16.67%
Weight Loss: 3 people, 12.50%
Fatigue (feeling of tiredness): 3 people, 12.50%
Eye Irritation: 3 people, 12.50%
Injury: 2 people, 8.33%
Cervicitis (inflammation of the uterine cervix): 2 people, 8.33%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 25.00%
High Blood Pressure: 5 people, 20.83%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 16.67%
Lung Disorder (lung disease): 4 people, 16.67%
Asthma: 3 people, 12.50%
Sleep Disorder: 2 people, 8.33%
Affective Disorder (mental disorder): 2 people, 8.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 8.33%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 8.33%
Stress And Anxiety: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and have Bronchospasm?

- Check whether Bronchospasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trileptal:

Trileptal (23,558 reports)

Bronchospasm treatments and more:

Bronchospasm (18,622 reports)

Browse all side effects of Trileptal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchospasm:

Bronchospasm (1,121 drugs)

Browse all the conditions that are associated with Bronchospasm:

Bronchospasm (1,099 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Trileptal) and Trileptal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.